You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pretreated Ovarian Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Ovarian Carcinoma, Soft Tissue Sarcoma Trial in Bordeaux, Lyon (Combination of trabectedin with durvalumab)

Active, not recruiting
  • Ovarian Carcinoma
  • Soft Tissue Sarcoma
  • Combination of trabectedin with durvalumab
  • Bordeaux, France
  • +1 more
May 4, 2021

Safety of Niraparib in Korean Primary and Recurrent Epithelial

Completed
  • Epithelial Ovarian Cancer
  • Seoul, Korea, Republic of
    Department of Obstetrics and Gynecology, University of Ulsan Col
Oct 11, 2023

Relapsed Ovarian Cancer Trial (Fluzoparib, Apatinib)

Not yet recruiting
  • Relapsed Ovarian Cancer
  • (no location specified)
Oct 7, 2023

Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 26, 2023

Ovarian Epithelial Carcinoma Trial (SZ011 CAR-NK)

Not yet recruiting
  • Ovarian Epithelial Carcinoma
  • SZ011 CAR-NK
  • (no location specified)
May 3, 2023

Ovarian Cancer Trial in France (tests to determine HRD status)

Not yet recruiting
  • Ovarian Cancer
  • tests to determine HRD status
  • Amiens, France
  • +3 more
Nov 22, 2023

Ovarian Clear Cell Carcinoma Trial (Zimberelimab, Metformin Hydrochloride)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • (no location specified)
Feb 25, 2023

Ovarian Cancer Trial (Aribulin;carboplatin;bevacizumab)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Jul 20, 2023

Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

Completed
  • Serous Ovarian Carcinoma
  • Low Grade Serous Ovarian Carcinoma
  • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
  • Lyon, France
    Hospices civils de Lyon
Feb 14, 2023

Ovarian Squamous Cell Carcinoma Trial in Niigata (MK-3475 (pembrolizumab))

Not yet recruiting
  • Ovarian Squamous Cell Carcinoma
  • MK-3475 (pembrolizumab)
  • Niigata, Japan
    Niigata University Medical & Dental Hosptal
Feb 20, 2023

Ovarian Clear Cell Carcinoma Trial (Camrelizumab)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • (no location specified)
Oct 29, 2022

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Mobile, Alabama
  • +7 more
Jan 24, 2023

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023

    Epithelial Ovarian Cancer: A Retrospective Study

    Recruiting
    • Epithelial Ovarian Cancer
    • Hematologic features
    • Shanghai, Shanghai, China
      Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
    Oct 16, 2023

    Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Ovarian Cancer
    • Maywood, Illinois
      Loyola University Medical Center
    Aug 1, 2023

    Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

    Not yet recruiting
    • Ovarian Carcinoma
    • PEP-DC1
    • +3 more
    • (no location specified)
    Jan 26, 2023

    Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

    Not yet recruiting
    • Ovarian Cancer Recurrent
    • Fluzopril Combined With Apatinib
    • (no location specified)
    Oct 22, 2023

    Ovarian Cancer Trial in Helsinki (Biomolecular profiling)

    Recruiting
    • Ovarian Cancer
    • Biomolecular profiling
    • Helsinki, Finland
      Helsinki University and Helsinki University Hospital
    Nov 1, 2023

    Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • Breast Cancer
    • Neratinib Oral Tablet
    • Ruxolitinib Oral Tablet
    • Dallas, Texas
      Baylor University Medical Center, Baylor Charles A Sammons Cance
    Aug 22, 2023

    Platinum-resistant Ovarian Cancer

    Not yet recruiting
    • Ovarian Cancer
    • pegylated liposomal doxorubicin
    • (no location specified)
    Aug 2, 2023

    Epithelial Cell Adhesion Molecule in Epithelial Ovarian

    Recruiting
    • Ovarian Carcinoma
      • Sohag, Egypt
      • +1 more
      Oct 8, 2022

      Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)

      Not yet recruiting
      • Ovarian Cancer Recurrent
      • Niraparib oral capsule
      • SBRT
      • Sutton, Surrey, United Kingdom
      • +1 more
      Aug 10, 2023

      Transforming Ovarian Cancer Diagnostic Pathways

      Not yet recruiting
      • Ovarian Cancer
        • Birmingham, United Kingdom
        • +2 more
        Nov 10, 2023